{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.1"},{"groupId":"OG001","value":"8.2"}]}],"title":"Central Reader 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.3"},{"groupId":"OG001","value":"12.2"}]}],"title":"Central Reader 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.7"},{"groupId":"OG001","value":"8.0"}]}],"title":"Central Reader 3"}],"denoms":[{"counts":[{"groupId":"OG000","value":"352"},{"groupId":"OG001","value":"352"}],"units":"Participants"}],"description":"TP \\[confirmed by SoT\\] central BIE PET finding and negative conventional imaging finding from the local reading","groups":[{"description":"Percentage of patient being upstaged to N1 (EEP)","id":"OG000","title":"Upstaged to N1"},{"description":"Percentage of patient being upstaged to M1 (EEP)","id":"OG001","title":"Upstaged to M1"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Conventional images within 60 days or at least 24 hours prior to rhPSMA-7.3 (18F) PET, followed by treatment within 60 days post IMP administration","title":"The Percentage of Patients Being Upstaged to N1 or M1 Disease. (Objective 6a)","type":"SECONDARY","unitOfMeasure":"percentage"}